Capella BioScience Company
Capella Bioscience engages in the discovery and development of monoclonal antibodies.
Industry:
Gene therapy
Headquarters:
London, England, United Kingdom
Employees Number:
1-10
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership